Current Edition

news

As Ebola outbreak rages, researchers find promise in Regeneron drug

(Credit: Flickr, NIAID ) Two experimental Ebola treatments, including a drug from Regeneron, are advancing to the next stage of a large clinical trial after an i...
Continue Reading →
news

Offering Merck’s experimental Ebola vaccine to pregnant women is a risky but necessary move, says GlobalData

Following the recent announcement from the WHO that Merck’s experimental Ebola vaccine V920 (rVSV-ZEBOV) will be offered to pregnant women in the Congo for the first...
Continue Reading →
Asia Pacific

Development progress in 2018 for acute ischemic stroke drugs will fuel market growth, says GlobalData

Activase (alteplase) is currently the only FDA-approved drug available for the treatment of acute ischemic stroke (AIS) in the 8MM*; however, novel drugs designed to...
Continue Reading →
Asia Pacific

Brand new type of cancer drug has potential to fill unmet needs in oncology market, says GlobalData

Following a study published in The Lancet Oncology regarding a brand new type of cancer drug that has shown promise in multiple cancer types in early Phase I/II tria...
Continue Reading →
Asia Pacific

Despite recent setbacks, the ophthalmology market still offers vast potential, says GlobalData

Despite the ophthalmology market experiencing several research and development (R&D) setbacks during 2018, the launch of three new drugs highlights that the mark...
Continue Reading →
news

New malaria drug starts clinical trials

Release of malaria parasites from red blood cell. After decades a new drug against malaria has been develope...
Continue Reading →